Through enterprise and study-level RBQM implementations across hundreds of trials, TRI has identified the recurring themes that prevent sponsors and CROs from achieving better data quality, greater trial efficiency, and stronger participant protection in the E6(R3) era.
Download the whitepaper to explore:
- How to govern multi-source trial data from wearables to ePRO in a way that supports RBQM and data integrity
- Why proportionate, risk-based oversight matters more in early-phase and complex innovative designs
- What end-to-end quality management aligned with QbD actually looks like in practice
- How to manage data quality and lineage across hybrid and decentralized trial models
- Why continuous expected versus actual review is the foundation of inspection-ready oversight
Fill in the from to get your copy.
